1mg
Showing 6501–6550 of 7910 results
-
Phenylephrine 2-O-Glucuronide (>90%)
Molecular Formula : C15H21NO8
-
Phenylephrone-d3 Hydrochloride
Molecular Formula : C9H9D3ClNO2
-
Phenylglycyl Cefaclor Hydrochloride (mixture of diastereomers)
Molecular Formula : C23H21ClN4O5S . xHCl
-
Phenylglyoxylic Acid-13C8
Molecular Formula : 13C8H6O3
-
Phloroglucinol-13C6
Molecular Formula : 13C6H6O3
-
Pholcodine 4-Oxide
Molecular Formula : C23 H30 N2 O5
-
Pholcodine-d3
Molecular Formula : C23H27D3N2O4
-
Pholcodine-N,N’-dioxide
Molecular Formula : C23 H30 N2 O6
-
Phomopsin A
Molecular Formula : C36H45ClN6O12
-
Phorbol
Molecular Formula : C20 H28 O6
-
Phospho-L-arginine Trisodium Salt
Molecular Formula : C6H12N4Na3O5P
-
Phosphorylethanolamine-d4
Molecular Formula : C2H4D4NO4P
-
Phthalic Acid (Phenyl-13C6, D4)
Molecular Formula : No Data Available
-
Physcion 1-Beta-D-Glucopyranoside
Molecular Formula : C22H22O10
-
Physcion 8-beta-D-glucoside
Molecular Formula : C22 H22 O10
-
Physcion-d3
Molecular Formula : C16H9D3O5
-
Physostigmine-d3
Molecular Formula : C15 D3 H18 N3 O2
-
Phytolaccagenin
Molecular Formula : C31H48O7
-
Picaridin-d3
Molecular Formula : C12H20D3NO3
-
Picolinafen-d4
Molecular Formula : C19D4H8F4N2O2
-
Picropodophyllotoxin-d3
Molecular Formula : C22H19D3O8
-
PIK-75
Molecular Formula : C16H14BrN5O4S
-
Pimozide-d5 (Major)
Molecular Formula : C28H24D5F2N3O
-
Pinacolone-d9
Molecular Formula : C26 H34 N2 O13
-
Pindolol-d7
Molecular Formula : C14 D7 H13 N2 O2
-
Pinosylvin
Molecular Formula : C14 H12 O2
-
Pinoxaden-d3
Molecular Formula : C23H29D3N2O4
-
Pioglitazone-d4 (major)
Molecular Formula : C19H16D4N2O3S
-
Pioglitazone-d4 Hydrochloride
Molecular Formula : C19H17D4ClN2O3S
-
Pipendoxifene (Piperidine-D10)
Molecular Formula : C29 D10 H22 N2 O3
-
Piperacillin-d5
Molecular Formula : C23 2H5 H22 N5 O7 S
-
Piperacilloic Acid
Molecular Formula : C23H29N5O8S
-
Piperaquine-d6 Tetraphosphate
Molecular Formula : C29H26D6Cl2N6•4H3PO4
-
Piperazinedione-carbonyl D-Phenyl-glycylampicillin Potassium Salt
Molecular Formula : C31 H33 K N6 O8 S
-
Piperiacetildenafil-d10
Molecular Formula : C24 D10 H21 N5 O3
-
Piracetam-d8
Molecular Formula : C6 D8 H2 N2 O2
-
Pirenzepine-d10 Dihydrochloride
Molecular Formula : C19H12D11Cl2N5O2
-
Pirenzepine-d8 Dihydrochloride
Molecular Formula : C19H15D8Cl2N5O2
-
Piretanide
Molecular Formula : C17 H18 N2 O5 S
-
Piretanide-d4 (Major)
Molecular Formula : C17H14D4N2O5S
-
Pirimicarb-d6
Molecular Formula : C11 2H6 H12 N4 O2
-
Piritramide
Molecular Formula : C27 H34 N4 O
-
Pirlimycin Hydrochloride
Molecular Formula : C17 H31 Cl N2 O5 S . x[HCl]
-
Piroxicam-d3
Molecular Formula : C15 2H3 H10 N3 O4 S
-
Pitavastatin-d5 Lactone
Molecular Formula : C25H17D5FNO3
-
Pitavastatin-d5 Sodium Salt
Molecular Formula : C25H18D5FNNaO4
-
Pivaloylglycine-13C2,15N
Molecular Formula : C513C2H1315NO3
-
PIVKA II (1C5), mAb, Mouse
Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II), also known as Des-γ-carboxy-prothrombin (DCP), is an abnormal form of prothrombin. Normally, the prothrombin’s 10 glutamic acid residues (Glu) in the γ-carboxyglutamic acid (Gla) domain at positions 6, 7, 14, 16, 19, 20,25, 26, 29 and 32 are γ-carboxylated to Gla by vitamin-K dependent γ- glutamyl carboxylase in the liver and then secreted into plasma. In patients with hepatocellular carcinoma (HCC), γ-carboxylation of prothrombin is impaired so that PIVKA-II is formed instead of prothrombin. PIVKA-II is considered as is an efficient biomarker specific for HCC.
-
PIVKA II (2D7), mAb, Mouse
Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II), also known as Des-γ-carboxy-prothrombin (DCP), is an abnormal form of prothrombin. Normally, the prothrombin’s 10 glutamic acid residues (Glu) in the γ-carboxyglutamic acid (Gla) domain at positions 6, 7, 14, 16, 19, 20,25, 26, 29 and 32 are γ-carboxylated to Gla by vitamin-K dependent γ- glutamyl carboxylase in the liver and then secreted into plasma. In patients with hepatocellular carcinoma (HCC), γ-carboxylation of prothrombin is impaired so that PIVKA-II is formed instead of prothrombin. PIVKA-II is considered as is an efficient biomarker specific for HCC.
-
PIVKA II (6C4), mAb, Mouse
Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II), also known as Des-γ-carboxy-prothrombin (DCP), is an abnormal form of prothrombin. Normally, the prothrombin’s 10 glutamic acid residues (Glu) in the γ-carboxyglutamic acid (Gla) domain at positions 6, 7, 14, 16, 19, 20,25, 26, 29 and 32 are γ-carboxylated to Gla by vitamin-K dependent γ- glutamyl carboxylase in the liver and then secreted into plasma. In patients with hepatocellular carcinoma (HCC), γ-carboxylation of prothrombin is impaired so that PIVKA-II is formed instead of prothrombin. PIVKA-II is considered as is an efficient biomarker specific for HCC.